YAP1 and cancer: In most cancers, unphosphorylated activated TAZ/YAP translocate into nucleus, which in turn binds with multiple transcriptional factors including TEAD1-4 to activate transcription of downstream targets to induce unstrained proliferation, metastasis, chemoresistance and cancer stem cell features, thus making them attractive therapeutic targets [8–10].